Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $834.99 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $246.88 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $216.75 | 2 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $123.34 | 1 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $114.85 | 1 | $0 (2023) |
| ABBVIE INC. | $55.76 | 3 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $44.64 | 2 | $0 (2024) |
| Corium, LLC | $21.63 | 1 | $0 (2023) |
| Neuronetics, Inc. | $11.14 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57.72 | 3 | ABBVIE INC. ($37.09) |
| 2023 | $219.01 | 8 | Teva Pharmaceuticals USA, Inc. ($114.85) |
| 2020 | $192.65 | 2 | Alkermes, Inc. ($98.60) |
| 2019 | $122.70 | 1 | Janssen Pharmaceuticals, Inc ($122.70) |
| 2017 | $242.91 | 3 | Sunovion Pharmaceuticals Inc. ($123.34) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Neuropsychiatry | ||||||
| 12/13/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/19/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: CNS | ||||||
| 10/19/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: CNS | ||||||
| 07/14/2023 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $6.98 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 07/14/2023 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $4.16 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 06/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $114.85 | General |
| Category: Central Nervous System | ||||||
| 04/06/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: CNS | ||||||
| 02/25/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $94.05 | General |
| Category: Neuroscience | ||||||
| 02/12/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $98.60 | General |
| Category: CNS | ||||||
| 05/22/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $122.70 | General |
| Category: Neuroscience | ||||||
| 11/28/2017 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: NEUROLOGY | ||||||
| 01/25/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $123.34 | General |
| Category: CNS | ||||||
| 01/18/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $95.56 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 54 | 112 | $17,630 | $6,554 |
| 2022 | 1 | 19 | 26 | $2,080 | $810.94 |
| 2021 | 2 | 111 | 262 | $25,560 | $9,390 |
| 2020 | 1 | 200 | 624 | $49,920 | $20,462 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 40 | $10,000 | $3,444 | 34.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 11 | 37 | $4,830 | $1,907 | 39.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 32 | 35 | $2,800 | $1,203 | 43.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 19 | 26 | $2,080 | $810.94 | 39.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 79 | 222 | $17,760 | $6,992 | 39.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 32 | 40 | $7,800 | $2,398 | 30.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 200 | 624 | $49,920 | $20,462 | 41.0% |
About Dr. Richard Marcus, M.D
Dr. Richard Marcus, M.D is a Psychiatry healthcare provider based in Pembroke, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871660910.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Marcus, M.D has received a total of $834.99 in payments from pharmaceutical and medical device companies, with $57.72 received in 2024. These payments were reported across 17 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($834.99).
As a Medicare-enrolled provider, Marcus has provided services to 384 Medicare beneficiaries, totaling 1,024 services with total Medicare billing of $37,217. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Pembroke, MA
- Active Since 11/30/2006
- Last Updated 07/27/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871660910
Products in Payments
- ARISTADA (Drug) $151.32
- LATUDA (Drug) $123.34
- INVEGA SUSTENNA (Drug) $122.70
- AUSTEDO (Drug) $114.85
- Aristada 441 mg (Drug) $95.56
- SPRAVATO (Drug) $94.05
- VRAYLAR (Drug) $55.76
- INGREZZA (Drug) $44.64
- Azstarys (Drug) $21.63
- NEUROSTAR TMS THERAPY SYSTEM (Device) $11.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.